/
Sign inStart free
Menu

Earnings call · Apr–Jun 2026

Alkem Laboratories Limited

Transcript filed on BSE on 20 Aug 2026 · 3 people from the company · 8 analysts asked questions

TL;DR

Alkem reported Apr–Jun 2026 revenue of ₹3,740 crore with 11% growth from a year earlier. India sales grew 10.3% while international grew 16%. EBITDA margin was 20.5%, but net profit fell 21.7% due to taxation. The company outperformed the Indian pharma market by 100 basis points.

The full notes: the guidance, numbers & KPIs, strategy, outlook, risks, what analysts asked.

Premium opens every call in full: the notes, the marked passages, search & topic jumps, for every company that files a transcript.

From the company

  • Purvi ShahHead of Investor Relations
  • Sandeep SinghManaging Director
  • Nitin AgrawalChief Financial Officer

Questions came from

Hosted by Tushar Manudhane of Motilal Oswal Financial Services

Topics in this call

Outlook 20Margins 11Prices 5Costs 5Capex & capacity 5Demand 4Orders & deals 3

Opening remarks

Sandeep SinghManaging Director

Thank you, Purvi. Good evening, everyone. Thank you for joining our call. The period under review has been one of continued execution of our strategy. While the operating environment remains dynamic, we have stayed focused on the fundamentals, strengthening our core business, improving operational efficiency and investing selectively in areas that can support a sustainable and profitable growth.

We are encouraged by the progress we are making across these priorities. At the same time, we remain conscious of external challenges and are maintaining a disciplined approach to capital allocation, costs and risk management.

Read the whole call: 163 paragraphs, 9 analysts' questions with every answer, 7 marked passages.

Premium opens every call in full: the notes, the marked passages, search & topic jumps, for every company that files a transcript.

Earlier calls

The transcript as the company filed it on BSE. Our own rules split it into speakers & sections; an unusual layout can trip them, so check the original PDF for anything important. Not a recommendation.

HV Investing Premium

Get the gist of each earnings call

See Premium plans

₹499 a month or ₹4,999 a year. Cancel anytime.

or start free, no card needed

Already a member?Sign in